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occidioides brasiliensis, which in their saprophytic mold
orm and under certain environmental conditions produce
icroconidia (< 5m). These propagules become air-born
nd are accidentally inhaled by man; once in the lungs
hey convert to the tissue e forms. Most patients are adult
ales engaged in aerosol-generating activities (agriculture,
orestry, masonry, speleology), with women and children
eing afﬂicted less often. The three mycoses initiate their
athologic expression in the lungs but extra-pulmonary dis-
emination is common mainly to mucous membranes, skin,
ymph nodes, liver, spleen, adrenals, bones, CNS and oth-
rs; these entities are systemic and one-organ affection
s rare. Signs and symptoms may be related to the res-
iratory tract but are more often referred to secondary
esions making it difﬁcult to conﬁrm suspicion on clinical evi-
ence alone. Image studies vary depending on the diseases’
ourse and include inﬁltrates, nodules, cavities, pleural
etraction, ﬁbrosis and calciﬁcations. Deﬁnitive diagnosis
s established only on mycological grounds through biop-
ies, direct examinations and cultures. The three etiologic
gents’ differential characteristics under the microscope
lus the type of propagules produced in cultures, allow
heir precise identiﬁcation. Availability of several indirect
ests to determine circulating antibodies and antigens and
lso of several DNA-based tests serve to conﬁrm diagnosis
nd facilitate follow-up studies. These mycoses are difﬁ-
ult to treat requiring prolonged courses and careful medical
upervision. Treatment has greatly improvedwith the advent
f the new triazoles (itraconazole, voriconazole, posacona-
ole) but amphotericin B remains a major therapy; recovery
s contingent on prompt diagnosis, patient’s immune status
nd stage of the mycosis at therapy initiation.
oi:10.1016/j.ijid.2010.02.1523
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The main challenges confronting us in the tropical
ycoses are 1) rapid and accurate diagnosis 2) the avail-
bility of appropriate therapy and 3) a rising incidence of
ertain infections. Diagnosis is dependent on the logical
ssociation between the clinical appearances and appropri-
te laboratory steps. However key features of fungi that aid
heir recognition are their size and the simple cultural and
istological techniques used to detect them. Use of con-
entional histopathology or immunopathological techniques
s highly effective in many cases but molecular tools are
ow used for some conditions including dermatophytosis and
porotrichosis. With some mycoses the process is simpler. In
ycetomas, for instance, histological or cultural evidence
an be obtained directly from sinuses or by biopsy.
Most new antifungals have not been proﬁled with trop-
cal mycoses in mind and there are few evidence-based
linical trials to establish usage or duration of therapy.
he commonest of these infections that present major
herapeutic problems are the mycetomas and chromoblasto-
ycosis. Fungal mycetomas seldom respond to normal doses
v
u
i
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f antifungals; whereas those caused by bacteria, actino-
ycetomas, respond to a range of antibacterials such as
apsone, amikacin, fusidic acid, imipenem etc unless they
re very extensive. There is only limited reporting of the
se of newer azoles, posaconazole and voriconazole in these
ycoses. Mycoses where there have been changes in epi-
emiology, suggesting, spread include tinea capitis. Spread
f Trichophyton tonsurans infections to South America and
est Africa are examples. Whereas HIV in many countries
s controlled through the use of antiretrovirals in infected
ndividuals late recognition is a feature in many areas of
he tropics and therefore there is a continuing risk of sys-
emic fungal infections presenting with skin lesions as their
rst and most obvious clinical manifestation. Being alert to
hese changes provides a rapid means of dealing with these
nfections.
oi:10.1016/j.ijid.2010.02.1524
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Candidemia is an important nosocomial infection, with
igh incidence and mortality rates. Strategies for the man-
gement of candidemia include prophylaxis and treatment
f established infection. Prophylaxis is more likely to ben-
ﬁt groups of patients with high incidence of candidemia,
uch as premature neonates, allogeneic hematopoietic stem
ell transplant recipients and high-risk liver transplant
ecipients. For the treatment of candidemia, various stud-
es have been conducted comparing different drugs, such
s ﬂuconazole, voriconazole, deoxycholate and liposomal
mphotericin B, and the echinocandins caspofungin, mica-
ungin and anidulafungin. In general, the echinocandins
epresent the best option for the initial treatment of can-
idemia. In addition to prophylaxis and treatment, attempts
o deﬁne a group of patients that may beneﬁt from early
mpiric or preemptive have been developed. These include
he development of prediction rules and the use of serum
iomarkers such as 1,3-beta-D-glucan and polymerase chain
eaction-base techniques.
oi:10.1016/j.ijid.2010.02.1525
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Human migration has always been associated with dis-
ase translocation. Over the last century the speed and
olume of international travel and migration has reached
nprecedented levels bringing the impact of globalization
nto every sector of society- economic, environmental,
olitical, socio-cultural, and health. As a consequence, the
